Moleculin Biotech Stock Probability of Future Stock Price Finishing Over 3.42
| MBRX Stock | USD 1.86 0.33 15.07% |
Moleculin |
Moleculin Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Moleculin Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Moleculin Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Moleculin Biotech generated a negative expected return over the last 90 days | |
| Moleculin Biotech has high historical volatility and very poor performance | |
| Moleculin Biotech may become a speculative penny stock | |
| Net Loss for the year was (29.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Moleculin Biotech currently holds about 58 M in cash with (24.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Moleculin Biotech has a poor financial position based on the latest SEC disclosures |
Moleculin Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Moleculin Stock often depends not only on the future outlook of the current and potential Moleculin Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Moleculin Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2 M | |
| Cash And Short Term Investments | 23.6 M |
Moleculin Biotech Technical Analysis
Moleculin Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Moleculin Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Moleculin Biotech. In general, you should focus on analyzing Moleculin Stock price patterns and their correlations with different microeconomic environments and drivers.
Moleculin Biotech Predictive Forecast Models
Moleculin Biotech's time-series forecasting models is one of many Moleculin Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Moleculin Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Moleculin Biotech
Checking the ongoing alerts about Moleculin Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Moleculin Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Moleculin Biotech generated a negative expected return over the last 90 days | |
| Moleculin Biotech has high historical volatility and very poor performance | |
| Moleculin Biotech may become a speculative penny stock | |
| Net Loss for the year was (29.77 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Moleculin Biotech currently holds about 58 M in cash with (24.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Moleculin Biotech has a poor financial position based on the latest SEC disclosures |
Additional Tools for Moleculin Stock Analysis
When running Moleculin Biotech's price analysis, check to measure Moleculin Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moleculin Biotech is operating at the current time. Most of Moleculin Biotech's value examination focuses on studying past and present price action to predict the probability of Moleculin Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moleculin Biotech's price. Additionally, you may evaluate how the addition of Moleculin Biotech to your portfolios can decrease your overall portfolio volatility.